Is NXGN undervalued or overvalued?
As of 2025-03-20, the Intrinsic Value of NextGen Healthcare Inc (NXGN) is 19.60 USD. This NXGN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 23.94 USD, the upside of NextGen Healthcare Inc is -18.10%. This means that NXGN is overvalued by 18.10%.
The range of the Intrinsic Value is 10.99 - 58.43 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 10.99 - 58.43 | 19.60 | -18.1% |
| DCF (Growth 10y) | 15.41 - 72.88 | 25.89 | 8.1% |
| DCF (EBITDA 5y) | 13.85 - 20.14 | 18.06 | -24.6% |
| DCF (EBITDA 10y) | 16.94 - 25.44 | 22.10 | -7.7% |
| Fair Value | -2.32 - -2.32 | -2.32 | -109.67% |
| P/E | (1.28) - 8.35 | 2.57 | -89.3% |
| EV/EBITDA | 8.33 - 15.45 | 12.78 | -46.6% |
| EPV | 1.63 - 3.16 | 2.39 | -90.0% |
| DDM - Stable | (1.33) - (13.48) | (7.40) | -130.9% |
| DDM - Multi | 12.20 - 97.14 | 21.73 | -9.2% |
| Market Cap (mil) | 1,606.37 |
| Beta | 0.48 |
| Outstanding shares (mil) | 67.10 |
| Enterprise Value (mil) | 1,820.07 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.76% |
| Cost of Debt | 12.38% |
| WACC | 7.09% |